BioSpace News Archive

Akero Therapeutics, Inc. today reported first quarter financial results for the period ending March 31, 2022.

Castle Biosciences, Inc. today announced a collaboration with Camille Schrier, Miss America 2020, to promote the potential of genetic testing and the IDgenetix® test to help improve treatment for mental health conditions.

Spectrum Pharmaceuticals today announced it will host a conference call to discuss the first quarter 2022 financial results and provide a corporate update on Thursday, May 12, 2022 at 4:30 p.m. Eastern/1:30 p.m. Pacific.

IMV Inc. today announced that it will hold a conference call and webcast on Friday, May 13, 2022, at 8:00 a.m. ET to discuss the company’s 2022 first quarter financial and operational results.

AVROBIO, Inc. announced that the company has granted a non-statutory stock option for the purchase of up to 63,000 shares of the company’s common stock to one new employee as an inducement award under the company’s 2019 Inducement Plan.

Sierra Oncology, Inc. today reported its financial and operating results for the first quarter ended March 31, 2022.

Forma Therapeutics Holdings, Inc. today reported financial results for the first quarter ended March 31, 2022.

BiomX to Host Key Opinion Leader Event on BX004 for Treatment of Pseudomonas Aeruginosa Infections in Cystic Fibrosis Patients.

Noema Pharma announces Luigi Costa, Chief Executive Officer, and Michael Gutch, Chief Financial Officer, will attend and present at two upcoming investor events.

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that management will participate in a fireside chat at the LifeSci Partners Immunology and Inflammation Symposium on Tuesday, May 10, 2022 at 3:30 p.m. ET.